NIH-funded research R01 grant

Exploring how Mycobacterium tuberculosis adapts through protein signaling

Official title: Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome

Funded at Seattle Children's Hospital · NIH-11011325 · Data updated 2026-11-12

This study is looking at how the tuberculosis bacteria communicate and adapt to their surroundings, which could help us find new ways to treat the infection.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startFebruary 3, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$575,240
NIH project number5R01AI170914-03
Project IDNIH-11011325 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with tuberculosis or those at high risk of developing the disease.

Less likely to help

Patients with non-tuberculosis bacterial infections or those without any bacterial infections may not benefit from this research.

What this research studies

This research investigates the complex signaling mechanisms used by Mycobacterium tuberculosis (Mtb) to adapt and survive. By examining the phosphorylation of proteins, which is a key process in bacterial signaling, the study aims to identify how these modifications affect gene expression and bacterial behavior. Using advanced techniques like quantitative mass spectrometry and mutant analysis, researchers will explore the roles of specific kinases in regulating Mtb's response to its environment. This could lead to a better understanding of how tuberculosis bacteria function and how they might be targeted for treatment.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating tuberculosis by targeting the signaling pathways that Mtb uses to survive.

How similar studies have gone: Previous research has shown success in understanding bacterial signaling mechanisms, indicating that this approach could yield valuable insights.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Grundner, Christoph — Seattle Children's Hospital
  • Study coordinator: Grundner, Christoph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.